These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

522 related items for PubMed ID: 22755438

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. High immunologic risk living donor kidney transplant using bortezomib in a novel induction regimen without acute antibody mediated rejection.
    Dunn TB, Borja-Cacho D, Chinnakotla S, Finger E, Tamayo G, Verghese P, Kim Y, Manivel C, Kandaswamy R, Matas A, Pruett T, Noreen H, Krefting P, Maurer D.
    Clin Transpl; 2011; ():381-7. PubMed ID: 22755435
    [Abstract] [Full Text] [Related]

  • 4. Proteasome inhibitor-based primary therapy for antibody-mediated renal allograft rejection.
    Walsh RC, Everly JJ, Brailey P, Rike AH, Arend LJ, Mogilishetty G, Govil A, Roy-Chaudhury P, Alloway RR, Woodle ES.
    Transplantation; 2010 Feb 15; 89(3):277-84. PubMed ID: 20145517
    [Abstract] [Full Text] [Related]

  • 5. Intensive plasmapheresis and intravenous immunoglobulin for treatment of antibody-mediated rejection after kidney transplant.
    Ruangkanchanasetr P, Satirapoj B, Termmathurapoj S, Namkhanisorn K, Suaywan K, Nimkietkajorn V, Luesutthiviboon L.
    Exp Clin Transplant; 2014 Aug 15; 12(4):328-33. PubMed ID: 25095710
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Lung transplantation across donor-specific anti-human leukocyte antigen antibodies: utility of bortezomib therapy in early graft dysfunction.
    Stuckey LJ, Kamoun M, Chan KM.
    Ann Pharmacother; 2012 Jan 15; 46(1):e2. PubMed ID: 22202499
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Reduction of alloantibodies via proteasome inhibition in cardiac transplantation.
    Patel J, Everly M, Chang D, Kittleson M, Reed E, Kobashigawa J.
    J Heart Lung Transplant; 2011 Dec 15; 30(12):1320-6. PubMed ID: 21968130
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Combination of Total Lymphoid Irradiation, Low-Dose IVIG and ATG as Rescue Therapy for Highly Sensitized and Antibody-Mediated Rejection Renal Transplant Recipients.
    Zhu D, Qi G, Tang Q, Li L, Yang C, Lin M, Wu B, Xu M, Cai J, Zhu T, Rong R.
    Clin Transpl; 2014 Dec 15; ():215-21. PubMed ID: 26281148
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Abrogation of anti-HLA antibodies via proteasome inhibition.
    Trivedi HL, Terasaki PI, Feroz A, Everly MJ, Vanikar AV, Shankar V, Trivedi VB, Kaneku H, Idica AK, Modi PR, Khemchandani SI, Dave SD.
    Transplantation; 2009 May 27; 87(10):1555-61. PubMed ID: 19461494
    [Abstract] [Full Text] [Related]

  • 15. Characterization of rejection episodes in patients following positive crossmatch and ABO-incompatible live donor renal transplantation.
    Kayler LK, Farber JL, Colombe B, LaCava D, Friedewald JJ, Ratner LE.
    Transpl Int; 2006 Feb 27; 19(2):128-39. PubMed ID: 16441362
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The acceptable reactive crossmatch (ARC), post-transplant monitoring, and their impact on kidney transplantation: a single center experience.
    Leone JP, Bowers V, Baliga R, Sanders C, LeFor W, Becker D, Thompson D, Resto-Ruiz S, Lopez-Cepero M.
    Clin Transpl; 2011 Feb 27; ():373-9. PubMed ID: 22755434
    [Abstract] [Full Text] [Related]

  • 18. A novel post-transplant alloantibody surveillance and intervention strategy that improves graft outcomes in sensitized renal transplant recipients.
    Kimball PM, King A.
    Clin Transpl; 2011 Feb 27; ():369-72. PubMed ID: 22755433
    [Abstract] [Full Text] [Related]

  • 19. De novo donor specific antibodies and patient outcomes in renal transplantation.
    DeVos JM, Patel SJ, Burns KM, Dilioglou S, Gaber LW, Knight RJ, Gaber AO, Land GA.
    Clin Transpl; 2011 Feb 27; ():351-8. PubMed ID: 22755430
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.